193
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

New dehydroabietic acid (DHA) derivatives with anticancer activity against HepG2 cancer cell lines as a potential drug targeting EGFR kinase domain. CoMFA study and virtual ligand-based screening

, , , &
Pages 2993-3003 | Received 20 Mar 2020, Accepted 16 Apr 2020, Published online: 04 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Moulay Ahfid El Alaouy, Marwa Alaqarbeh, Mohamed Ouabane, Hanane Zaki, Mohamed ElBouhi, Hassan Badaoui, Youness Moukhliss, Abdelouahid Sbai, Hamid Maghat, Tahar Lakhlifi & Mohammed Bouachrine. (2023) Computational Prediction of 3,5-Diaryl-1H-Pyrazole and spiropyrazolines derivatives as potential acetylcholinesterase inhibitors for alzheimer disease treatment by 3D-QSAR, molecular docking, molecular dynamics simulation, and ADME-Tox. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now

Articles from other publishers (3)

Chengyang Ni, YaJu Wu, Mei Ran, Jingyan Li, Hong Li, Cai Lan, Jian Liu, Ping Dai, Jianming Wu & Fangyao Li. (2022) Design, synthesis and evaluation of novel dehydroabietic acid-dithiocarbamate hybrids as potential multi-targeted compounds for tumor cytotoxicity. Arabian Journal of Chemistry 15:10, pages 104145.
Crossref
Meng Hao, Jianwei Xu, Houpeng Wen, Jiawei Du, Shaoyong Zhang, Min Lv & Hui Xu. (2022) Recent Advances on Biological Activities and Structural Modifications of Dehydroabietic Acid. Toxins 14:9, pages 632.
Crossref
Jun Kan, Biqian Fu, Ruisheng Zhou, Daihan Zhou, Yufang Huang, Hongwei Zhao, Yunlong Zhang, Yuming Rong, Jun Dong, Liangping Xia, Shanshan Liu, Qiuling Huang, Nannan Wang, Na Ning, Bei Zhang & Enxin Zhang. (2022) He-Chan Pian inhibits the metastasis of non-small cell lung cancer via the miR-205-5p-mediated regulation of the GREM1/Rap1 signaling pathway. Phytomedicine 94, pages 153821.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.